Vishwas Seshadri | Chief Executive Officer |
Joseph Vazzano | Chief Financial Officer |
Dmitriy Grachev | Chief Medical Officer |
Brian Kevany | Chief Technical Officer, Head of Research |
Madhav Vasanthavada | Vice President, Business Development |
Greg Gin | Vice President, Investor Relations and Corporate Communications |
Maury Raycroft | Jefferies |
Kristen Kluska | Cantor Fitzgerald |
James Molloy | A.G.P./Alliance Global Partners |
Greetings. Welcome to the Abeona Therapeutics First Quarter '23 Portfolio Update Conference Call. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to your host, Greg Gin, Vice President of Investor Relations and Corporate Communications.
You may begin.